
PetMed Express, Inc.
- Jurisdiction
United States - LEI
529900PGHW5ASJ1AZL48 - ISIN
US7163821066 (PETS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
8
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. Read full profile
Stock price
Fundamentals
- Net revenue
€212.04M - Gross margin
26.2% - EBIT
€476.44K - EBIT margin
0.2% - Net income
€306.46K - Net margin
0.1%
Statement period: - (published )
Dividends
- Last dividend amount
-
$0.30 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
54.3%
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Silvercape Investments Ltd | N/A |
|
|
|
|
Silvercape Investments Ltd | N/A |
|
|
|
|
Earnings Calls
Latest earnings call: June 11, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |